Lobbying Filing Details

Total Spending

$500,000

Activities

3

Lobbyists

2

Gov't Entities

6

Filing Information
Filing UUID:
3b173ed8-c5ec-4f24-b65a-08c7e2b663f4
Type:
Q2 - 2nd Quarter - Report
Period:
2025 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 21, 2025 at 3:27 PM
Income:
$0
Expenses:
$500,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Michael Mattoon, Vice President, Government Affairs & Policy - Acadia Pharmaceuticals
Registrant
ACADIA PHARMACEUTICALS

Biopharmaceutical company

San Diego, California
Client
ACADIA PHARMACEUTICALS
California, United States of America
Lobbying Activities (3)
Activity 1
Health Issues

Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).

Lobbyists (2)
  • MR. MICHAEL MATTOON
  • SARAH TELLOCK
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Medicare/Medicaid

Implementation of the Inflation Reduction Act of 2022, Issues related to protecting patient access to medicines in Medicare, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Orphan Cures Act (HR 946, S 1862), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Accelerating Kids Access to Care Act (HR 1509, S 752).

Lobbyists (2)
  • MR. MICHAEL MATTOON
  • SARAH TELLOCK
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Taxation/Internal Revenue Code

Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).

Lobbyists (2)
  • MR. MICHAEL MATTOON
  • SARAH TELLOCK
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 11, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.